Side-by-side comparison of AI visibility scores, market position, and capabilities
Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.
Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.
Pasadena life science campus REIT (NYSE: ARE) with 39.7M RSF at $25.7B market cap; largest company lease ever (466,598 RSF/16-year pharma at San Diego Campus Point) and $3.12B 2024 revenue competing with Healthpeak for biotech lab REIT.
Alexandria Real Estate Equities, Inc. is a Pasadena, California-based life science real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: ARE) as an S&P 500 REIT — operating as the preeminent owner, operator, and developer of collaborative life science, technology, and agtech Megacampus ecosystems in AAA innovation cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland/DC, Research Triangle, and New York City. As of June 30, 2025, Alexandria has a $25.7 billion total market capitalization and manages 39.7 million rentable square feet (RSF) of operating properties and 4.4 million RSF of Class A/A+ properties under construction. In 2024, Alexandria reported $3.12 billion in revenue (+8.20%). The company executed its largest single lease in history — a 16-year agreement with a multinational pharmaceutical tenant for 466,598 RSF at the Campus Point Megacampus in San Diego (98.8% occupied). Executive Chairman and Founder: Joel Marcus; Co-CEOs: Stephen Richardson and Peter Moglia. Founded 1994.
Healthpeak Properties vs
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.